Anticancer Ru II and Rh III Piano‐Stool Complexes that are Histone Deacetylase Inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Anticancer Ru II and Rh III Piano‐Stool Complexes that are Histone Deacetylase Inhibitors ; volume:81 ; number:12 ; year:2016 ; pages:1276-1280 ; extent:5
ChemPlusChem ; 81, Heft 12 (2016), 1276-1280 (gesamt 5)
- Creator
-
Cross, Jasmine M.
Blower, Tim R.
Gallagher, Natalie
Gill, Jason H.
Rockley, Kimberly L.
Walton, James W.
- DOI
-
10.1002/cplu.201600413
- URN
-
urn:nbn:de:101:1-2022110705494184308044
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cross, Jasmine M.
- Blower, Tim R.
- Gallagher, Natalie
- Gill, Jason H.
- Rockley, Kimberly L.
- Walton, James W.
Other Objects (12)
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Design and Synthesis of Histone Deacetylase Inhibitors with Antiplasmodial and Anticancer Activities
Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor
Histone deacetylase 6 in cancer
Design, Synthesis and Biological Evaluation of Anti-Cancer and Anti-Parasitic Histone Deacetylase Inhibitors
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Design and Synthesis of Histone Deacetylase Inhibitors with Antiplasmodial and Anticancer Activities
Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor
Histone deacetylase 6 in cancer
Design, Synthesis and Biological Evaluation of Anti-Cancer and Anti-Parasitic Histone Deacetylase Inhibitors
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Design and Synthesis of Histone Deacetylase Inhibitors with Antiplasmodial and Anticancer Activities
Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor
Histone deacetylase 6 in cancer
Design, Synthesis and Biological Evaluation of Anti-Cancer and Anti-Parasitic Histone Deacetylase Inhibitors
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors